Dapatag-M 5 | 500 Tablets
Composition : Dapagliflozin 5 mg, Metformin 500 mg ER Tablets
Read MoreTherapeutic Segment : Diabetic Care
Packing : 1 x 10 (Alu-Alu)
Dosage : As directed by Physician
Product Information
Dapatag-M 5 | 500 Tablets is a combination oral antidiabetic medication used for the management of Type 2 Diabetes Mellitus. This dual-action therapy helps improve glycemic control by reducing hepatic glucose production, improving insulin sensitivity, and promoting urinary glucose excretion. The extended-release formulation of Metformin ensures sustained glucose control with better gastrointestinal tolerability.
- Type 2 Diabetes Mellitus
- Cardiovascular disease
- Usually one tablet once daily with meals
- Swallow the tablet whole; do not crush or chew the extended-release tablet
- Use as directed by the physician.
Dapatag-M 5 | 500 Tablets contains Dapagliflozin, which is a SGLT2 (sodium-glucose co-transporter 2) inhibitor that reduces blood glucose levels by preventing glucose reabsorption in the kidneys and increasing its excretion through urine. Metformin decreases hepatic glucose production, reduces intestinal glucose absorption, and enhances insulin sensitivity in peripheral tissues. Together, they provide complementary mechanisms to effectively control blood glucose levels.
Dapatag 10 mg Tablets | Dapatag 5 mg Tablets
Dapatag-M 10 | 1000 Tablets | Dapatag-M 10 | 500 Tablets
Dapatag-M 5 | 1000 Tablets | Dapatag-M 5 | 500 Tablets
